Generic antiretroviral drugs in developing countries: friends or foes?
- PMID: 24378755
- DOI: 10.1097/QAD.0000000000000170
Generic antiretroviral drugs in developing countries: friends or foes?
Abstract
Although second-line generic antiretroviral drugs are of great value in developing countries, there are concerns regarding their quality. We studied a generic Lopinavir/ritonavir (200/50 mg; Arga-L, India) marketed in the Republic of Congo but not prequalified by WHO. Despite adequate quantitative and qualitative drug content, Arga-L had a bio-availablility of 10% compared with Kaletra. To avoid selection of drug-resistant HIV, rigorous pharmacological monitoring of generic drugs not prequalified by WHO must be a priority.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
